Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-12-28
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-23 (study day 58.0); relationship: POSSIBLE
mild
assessed
Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2014-02-11 (study day 46.0); relationship: POSSIBLE
mild
assessed
Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2014-02-18 (study day 53.0); relationship: POSSIBLE
moderate
assessed
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04-24 (study day 118.0); relationship: POSSIBLE
Data queries
No data queries.